Explainer

ADHD Brain vs. Normal Brain: What MRI Studies Actually Show

ADHD brains differ only slightly from typical brains: a 2017 MRI study of 3,242 people found five deep-brain regions smaller, by small margins.

Mental Health Stats Research Team 6 min read

Key Takeaways

  • On average, ADHD brains differ only slightly from neurotypical brains: in a 2017 MRI mega-analysis of 1,713 people with ADHD and 1,529 controls, five deep-brain structures were smaller, with effect sizes of d = -0.11 to -0.19[1].d = -0.19[1]
  • The ADHD brain follows the typical maturation pattern but later: half of cortex sites reached peak thickness at an average age of 10.5 in youth with ADHD versus 7.5 in controls in a 2007 NIMH study[2].3 years[2]
  • Differences are clearest in children; a 2019 study of 2,246 people with ADHD and 1,934 controls found lower cortical surface area in children but no differences in adolescents or adults[3].d = -0.21[3]
  • In a U.S. population sample of 10,736 children aged 9 to 10, only 11 of 79 brain measures differed by ADHD status, with effect sizes of -0.11 to -0.06[4].11 of 79[4]
  • No brain scan can diagnose ADHD in an individual: CDC states there is no single test to diagnose ADHD[5], and the FDA-authorized EEG aid is not to be used as a stand-alone diagnostic tool[6].No single test[5]
How to read these numbers: "Normal brain" in this research means typically developing control participants without ADHD. Every figure below is a group average. Most of the effect sizes are small: brains of people with and without ADHD overlap heavily, which is why a single scan cannot show whether a person has ADHD.

ADHD Brain vs. Normal Brain: The Short Answer

The ADHD brain vs. normal brain difference is a matter of small average gaps in size, maturation timing and network activity, not a visibly different organ. The largest structural MRI study of its kind when published in 2017 pooled scans of 1,713 people with ADHD and 1,529 controls from 23 sites[1].

Five subcortical structures were slightly smaller in the ADHD group, and the gap was strongest in children under 15; in adults the differences were not statistically significant[1].

No single test, brain imaging included, can diagnose ADHD, according to CDC[5]. Clinicians instead gather information about behavior at home, at school and with peers, as recommended by the American Academy of Pediatrics and summarized by CDC[5].

This article covers structure, development and network activity. Brain chemistry is covered in ADHD and dopamine, genes and prenatal risk factors in what causes ADHD, and how common ADHD is on the ADHD statistics page.

Average age at which half of cortex sites reached peak thickness, youth with ADHD vs. without
10.5 vs. 7.5

The NIMH team scanned 446 young people, most at least twice, and found the same back-to-front maturation sequence in both groups, delayed by about three years on average in some regions in ADHD.

"half of 40,000 cortex sites attained peak thickness at an average age of 10.5, compared to age 7.5"

National Institute of Mental Health(2007) View Source

Is the ADHD Brain Smaller?

On average, slightly. A 10-year NIMH study of 152 children and adolescents with ADHD and 139 matched controls found total cerebral volume 3.2% smaller and cerebellar volume 3.5% smaller in the ADHD group after adjustment[7].

The 2017 ENIGMA mega-analysis narrowed the picture to specific deep-brain structures[1]. The nucleus accumbens, amygdala, caudate, hippocampus and putamen were smaller in ADHD, while the pallidum and thalamus showed no difference[1].

A 2019 follow-up from the same consortium compared the cortex, the brain's outer layer, in 2,246 people with ADHD and 1,934 controls across 36 centers[3]. Children with ADHD had lower surface area, mainly in frontal, cingulate and temporal regions, with the largest effect for total surface area (d = -0.21)[3].

Cortical thickness was lower in children with ADHD only in the fusiform gyrus and temporal pole[3]. The authors said the results confirmed involvement of the frontal cortex in ADHD[3].

ADHD vs. Neurotypical Brains in Major Imaging Studies

StudySampleFinding in ADHD groupSize of difference
NIMH longitudinal MRI (2002)152 ADHD, 139 controls, ages 4.5-19Total cerebral volume smaller-3.2%
ENIGMA subcortical (2017)1,713 ADHD, 1,529 controls, ages 4-63Accumbens, amygdala, caudate, hippocampus, putamen smallerd -0.11 to -0.19
ENIGMA cortex (2019)2,246 ADHD, 1,934 controlsLower surface area in children onlyd -0.21 (total area)
ABCD Study (2022)949 ADHD, 9,787 without, ages 9-1011 of 79 measures lowerd -0.11 to -0.06
White matter mega-analysis (2023)6,993 youths, ages 6-18Lower FA in inferior longitudinal and left uncinate fasciculiLargest d -0.3

Selected large structural and diffusion MRI studies comparing people with ADHD and controls; negative values mean smaller or lower in the ADHD group[7][1][3][4][8].

1The 2002 figure is the adjusted difference in mean total cerebral volume; the other studies report Cohen's d effect sizes.

2FA (fractional anisotropy) is a diffusion MRI measure used as an index of white matter microstructure.

3In the 2023 white matter study, 951 participants had enough clinical data for an ADHD diagnosis and 4,884 for its absence[8].

Sources

  • •Castellanos et al., JAMA, 2002
  • •Hoogman et al., Lancet Psychiatry, 2017
  • •Hoogman et al., Am J Psychiatry, 2019
  • •Bernanke et al., Lancet Psychiatry, 2022
  • •Sudre et al., Biol Psychiatry, 2023

Cohen's d (effect size)

A standardized measure of the gap between two group averages, expressed in standard deviations. In ADHD imaging studies a negative d means the measure was smaller or lower in the ADHD group. The closer d is to zero, the more the two groups overlap.

Related Terms

effect size
standard deviation
mega-analysis

Source: Statistical convention used in the ENIGMA and ABCD Study analyses cited here

Does the ADHD Brain Develop Later Than a Typical Brain?

The strongest evidence for a timing difference comes from a 2007 NIMH study, published in the Proceedings of the National Academy of Sciences, that tracked cortical thickness at about 40,000 points in 446 participants ranging from preschoolers to young adults[2].

In youth with ADHD, the cortex followed the typical back-to-front maturation pattern but was delayed by about three years on average in some regions[2]. The lag was largest in frontal areas that support control of thinking, attention and planning, and the middle prefrontal cortex lagged by five years[2].

The motor cortex was the only area that matured faster in ADHD than in controls, a mismatch the researchers suggested might relate to restlessness and fidgeting[2].

The ENIGMA subcortical data point the same way. Effect sizes were larger in children under 15 than in adults over 21, for example d = -0.18 versus -0.08 for the putamen, which the authors read as a delay of maturation[1].

That analysis was cross-sectional, comparing different people at different ages, so "delay" describes group trajectories rather than a timetable for any one child[1].

How Brain Activity and Wiring Differ in ADHD

Functional MRI measures activity while people perform tasks. A 2012 meta-analysis of 55 task-based fMRI studies, 39 in children and 16 in adults, found that children with ADHD showed less activation in the frontoparietal network, which supports executive function, and in the ventral attention network[9].

The same children showed more activation in the default, ventral attention and somatomotor networks[9]. Adults with ADHD showed less frontoparietal activation and more activation in the visual, dorsal attention and default networks[9].

Popular descriptions of an overactive default mode network in ADHD draw on findings like these. The meta-analysis measured activation differences, not mind-wandering itself.

Resting-state results are less consistent. A 2021 meta-analysis of 30 resting-state fMRI studies, covering 1,094 participants with ADHD and 884 controls, found no significant spatial convergence of over- or under-connectivity across studies[10].

White matter, the brain's long-distance wiring, shows small differences. A 2023 mega-analysis of 6,993 youths aged 6 to 18 from five cohorts linked both ADHD diagnosis and ADHD symptoms to lower fractional anisotropy in the inferior longitudinal and left uncinate fasciculi[8].

The largest case-control effect in that study was d = -0.3, and the same pattern was not present for anxiety, mood or other externalizing problems[8].

Can a Brain Scan Show ADHD?

Not in an individual. CDC describes diagnosis as a process with several steps and notes that sleep disorders, anxiety, depression and some learning disabilities can produce symptoms similar to ADHD[5].

Imaging researchers agree. When the NIMH maturation study was released, lead author Philip Shaw said the delay could only be detected across a very large number of children and could not yet be detected from the scans of one individual[2].

"Brain imaging is still not ready for use as a diagnostic tool in ADHD." Philip Shaw, M.D., NIMH, 2007[2]

Population data reinforce the point. In the ABCD Study, a sample of 10,736 U.S. children aged 9 to 10 representative of the population, children with ADHD differed only modestly from peers, and the authors said research on diagnostic biomarkers may need other methods[4].

The 2023 white matter study likewise concluded that diffusion imaging used in isolation has limited clinical utility for ADHD[8].

One brain-based device FDA has authorized as an ADHD assessment aid, the NEBA System, measures the EEG theta/beta ratio in patients aged 6 to 17[6]. FDA's decision summary limits it to confirmatory support for a completed clinical evaluation, or support for a decision to pursue further testing, and states it is not a stand-alone tool for evaluation or diagnosis[6].

How clinical evaluations work, from rating scales to interviews, is covered in ADHD test.

Do ADHD Medications Change the Brain?

The large imaging studies found no sign that stimulant treatment explains the structural differences. In the 2017 ENIGMA mega-analysis, psychostimulant use did not influence the results, and the authors wrote that their data refute medication effects on brain volume suggested by earlier meta-analyses[1].

The 2002 NIMH study found the opposite of a shrinking effect[7]. Previously unmedicated children with ADHD had 10.7% smaller total white matter volume than controls and 8.9% smaller than medicated children with ADHD[7].

Brain growth curves in that study ran roughly parallel to controls for every structure except the caudate, which the authors read as early influences that are fixed, nonprogressive and unrelated to stimulant treatment[7].

These are observational comparisons, not randomized trials, so they show an association rather than proof that medication changes brain structure in either direction. Drug classes and trial results are covered in ADHD meds.

The Adult ADHD Brain vs. the Child ADHD Brain

Structural differences fade with age in the large datasets. In ENIGMA's subcortical analysis, case-control differences in adults were not statistically significant[1], and the 2019 cortical analysis found no surface area or thickness differences in adolescents or adults[3].

That does not mean adult ADHD lacks a brain basis. Adults in task-based fMRI studies still showed lower frontoparietal activation than controls[9].

In the 2019 study, surface area also tracked attention problems in a general-population sample, which the authors said extends evidence that ADHD behaves as a continuous trait rather than a separate category[3].

Shaw's team suggested that a typical but delayed maturation pattern could help explain why many youth eventually seem to grow out of the disorder[2]. Figures by age group are on the children with ADHD and adults with ADHD pages.

Why ADHD Brain Studies Disagree

Early ADHD imaging studies were small and often failed to replicate[3]. The ENIGMA ADHD Working Group was formed to address inadequate sample sizes and methodological differences across those studies[1].

Sample type matters as well. Clinic-based studies recruit referred patients, while the ABCD Study drew children representative of the U.S. population and found only modest differences[4].

The 2021 resting-state meta-analysis attributed its null result to heterogeneity in participants, procedures and analytic choices, as well as in ADHD pathophysiology itself[10].

Family background is part of the picture: in the 2019 ENIGMA cortex study, surface area showed familial effects in several regions[3]. Twin and genome findings are summarized in is ADHD genetic.

Frequently Asked Questions

Sources & References

  1. Hoogman M, Bralten J, Hibar DP, et al. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. The Lancet Psychiatry. Published 2017. Accessed October 2026. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(17)30049-4/abstract [Link]
  2. National Institute of Mental Health. Brain matures a few years late in ADHD, but follows normal pattern. NIMH. Published 2007. Accessed October 2026. https://www.nimh.nih.gov/news/science-updates/2007/brain-matures-a-few-years-late-in-adhd-but-follows-normal-pattern [Link]
  3. Hoogman M, Muetzel R, Guimaraes JP, et al. Brain imaging of the cortex in ADHD: a coordinated analysis of large-scale clinical and population-based samples. American Journal of Psychiatry. Published 2019. Accessed October 2026. https://psychiatryonline.org/doi/10.1176/appi.ajp.2019.18091033 [Link]
  4. Bernanke J, Luna A, Chang L, Bruno E, Dworkin J, Posner J. Structural brain measures among children with and without ADHD in the Adolescent Brain and Cognitive Development Study cohort: a cross-sectional US population-based study. The Lancet Psychiatry. Published 2022. Accessed October 2026. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(21)00505-8/abstract [Link]
  5. Centers for Disease Control and Prevention. Diagnosing ADHD. CDC. Published 2024. Updated July 2026. Accessed October 2026. https://www.cdc.gov/adhd/diagnosis/index.html [Link]
  6. U.S. Food and Drug Administration. De novo decision summary: Neuropsychiatric EEG-Based Assessment Aid for ADHD (NEBA) System (K112711). FDA. Accessed October 2026. https://www.accessdata.fda.gov/cdrh_docs/reviews/K112711.pdf [Link]
  7. Castellanos FX, Lee PP, Sharp W, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA. Published 2002. Accessed October 2026. https://jamanetwork.com/journals/jama/fullarticle/195386 [Link]
  8. Sudre G, Norman L, Bouyssi-Kobar M, Price J, Shastri GG, Shaw P. A mega-analytic study of white matter microstructural differences across 5 cohorts of youths with attention-deficit/hyperactivity disorder. Biological Psychiatry. Published 2023. Accessed October 2026. https://www.biologicalpsychiatryjournal.com/article/S0006-3223(22)01629-8/abstract [Link]
  9. Cortese S, Kelly C, Chabernaud C, et al. Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. American Journal of Psychiatry. Published 2012. Accessed October 2026. https://psychiatryonline.org/doi/10.1176/appi.ajp.2012.11101521 [Link]
  10. Cortese S, Aoki YY, Itahashi T, Castellanos FX, Eickhoff SB. Systematic review and meta-analysis: resting-state functional magnetic resonance imaging studies of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry. Published 2021. Accessed October 2026. https://www.jaacap.org/article/S0890-8567(20)31414-3/fulltext [Link]

Related Statistics